Evolving Insights - From Curiosity to Clarity

India Auto Ancillaries: At the Cusp of a Multi Year Upcycle

The sector is entering a multi-year upgrade cycle where regulation, premiumization, and electrification converge to lift content-per-vehicle (CPV) and expand profit pools. My deep-dive (Q1 FY26 based) maps the real inflection points and who benefits.

Note that the report has been created using the investor presentations and concalls of five market leaders, none of which are recommendations by any means.

Why this matters now?

  • 2W safety mandate (Jan ’26 ABS): Unlocks a step-change in braking, sensors, and clusters.
  • LED & interior premiumization: UV-heavy mix and feature upgrades push CPV higher.
  • EV/connected architecture: Wiring, controllers, antennas, e-cockpits become mainstream.
  • Exports recovering: PV/2W export rebound adds a second growth engine.
  • Capex + R&D flywheel: Leaders are investing through the cycle—visibility > volatility.

What you’ll get in the report?

  • TAM today vs 2030, with segment-level build-ups
  • Company guidance roll-ups and must-track KPIs
  • Clear beneficiary map by theme (safety, LED, EV, aesthetics)
  • Key Management Quotes and Snippets

If you’re hunting durable compounders in megatrends, this is the moment to study auto-ancillaries in detail. Hope this report will be helpful!

Disc: not a buy/sell recommendation

India Auto Ancillaries - Key Insights from Market Leaders.pdf (1.7 MB)

10 Likes

Entero Healthcare: Riding India’s Great Pharma Distribution Consolidation

India’s pharma distribution is where the US was pre-consolidation—fragmented, inefficient, and ripe for roll-ups. Entero is executing a hyperscale playbook (50+ acquisitions in ~8 years), growing faster than the market, expanding margins, and guiding for materially lower working capital (WC) days. If those promises land, the narrative shifts from “cash-burning consolidator” to “scaled platform with improving ROCE.” Not a recommendation; do your own research.


1) Why this space, why now

  • The US precedent: Pharma distribution evolved from thousands of mom-and-pop wholesalers to three full-line giants (McKesson, Cardinal, AmerisourceBergen/CF). The result was scale economics, superior service levels, and outsized wealth creation—driven largely by disciplined inorganic growth and integration.
  • India’s starting line: National distributors hold only ~8–10% share today vs 95%+ Germany, 90%+ US, 40%+ China. Most of India is still served by local, traditional retailers/wholesalers.
  • The setup: Share of national distributors in India is expected to double to 20–30% in ~3 years, implying 25%+ CAGR for scaled platforms and catalyzing rapid consolidation. Key players: Entero, Keimed, Ascent, Apollo, others.

2) The Entero thesis in one frame

“Consolidate → Integrate → Scale → Sweat WC → Expand margins → Lift ROCE.”

  • Hyperscale consolidator: 50+ acquisitions in ~8 years, with most scaling well post-integration.
  • Outgrowing the market: Since inception, Entero has grown at ~1.5–2× industry growth.
  • Margin lift underway: EBITDA margins improved from ~1.2% → ~3.5%; EBITDA grew ~67% over the last 5 years.
  • Where it stumbled: Working capital drag led to negative operating cash flow; lofty starting valuations amplified the pain.

3) What changes the story from here

a) Working capital relief
Management guides WC days down to ~60 this year. If delivered, cash conversion flips positive, debt intensity falls, and ROCE improves.

b) Margin trajectory
EBITDA margins guided to ~4.5–5% over the next few years—helped by scale, network density, procurement leverage, SKU mix, and IT/automation.

c) Operating leverage from matured acquisitions
As integration synergies compound (shared tech, procurement, logistics routing, credit controls), fixed-cost absorption improves.

d) End-market tailwinds
The Indian Pharma Market (IPM) outlook remains constructive—benefiting scaled distributors with national reach and compliance readiness.

e) Valuation reset
Stock now sits in a “pessimism zone” at <1× sales and ~₹4,700 Cr market cap (as noted). If WC and margins normalize, multiple-re-rating becomes plausible.

f) Portfolio approach
Start small, build with evidence: add as WC days fall, margins expand, and ROCE trends up.


4) Sketching the pay-off (illustrative)

  • Topline can be 7500-8500Cr by FY28
  • Conservative PAT view (2-year lens): ₹250–300 Cr.
  • Exit multiple thought-experiment: With few local comps, assume 25–35× P/E for a scaled, cash-converting distributor.
  • Mentally I am thinking a much longer term game with a much higher topline and bottomline number but let’s keep it at this for now

Implied market-cap range:

  • ₹250 Cr PAT @ 25× → ₹6,250 Cr (~+33% vs ₹4,700 Cr)
  • ₹250 Cr PAT @ 35× → ₹8,750 Cr (~+86%)
  • ₹300 Cr PAT @ 25× → ₹7,500 Cr (~+60%)
  • ₹300 Cr PAT @ 35× → ₹10,500 Cr (~+123%)

Interpretation: If WC/margin/ROCE upgrades materialize, the asymmetry is meaningful. If they don’t, the stock can stay stuck.


5) Why Entero (vs legacy local networks)

  • Procurement power: Better terms with manufacturers; improved fill rates.
  • Network density: Route optimization, lower drop costs, faster turns.
  • Tech + compliance: Tighter credit controls, EDI, traceability, and analytics.
  • Playbook effects: Repeatable M&A integration across regions/SKUs.

6) Key risks to track

  1. Growth deceleration vs IPM (losing the outgrowth edge)
  2. IPM slowdown (macro/regulatory pricing pressure)
  3. WC days fail to fall (cash conversion stays weak)
  4. Margins stall below the 4.5–5% glide path
  5. Share loss in core clusters or integration missteps

7) What I’d watch each quarter (simple checklist)

  • WC days & OCF: Are days trending to ~60? Is OCF turning structurally positive?
  • EBITDA margin: Is the path toward 4.5–5% intact?
  • ROCE: Lifting alongside lower WC and better margins?
  • Like-for-like growth vs IPM: Still 1.5–2× industry?
  • Acquisition integration: Revenue synergies, procurement benefits, bad-debt discipline.
  • Debt metrics: Net debt/EBITDA drifting down as cash conversion improves.

8) Bottom line

India’s pharma distribution is mid-transition from fragmentation to scale. Entero sits on the right side of that shift with a proven roll-up, improving unit economics, and a credible WC/margin/ROCE improvement roadmap. At <1× sales, the risk/reward skews favorableif execution lands. The unlock is cash conversion; everything else follows.

Disclosure: This is not a recommendation. Educational content only. Please do your own research and consider your risk profile before making any investment decisions.

7 Likes

8000Cr @4.5% ebitda gives 360Cr - 80 (Interest+Depre)=280Cr , 25% tax gives around 220Cr PAT in best case scenario. Isn’t it ?

Best case scenario:

Topline growth of 25%+ which comes to around 9500Cr in FY28
OPM at 5% which gives us an EBITDA of 470Cr
PAT comes to around 300Cr+

30-35x gives you a MC of 9000-11500Cr

But one should have much more moderate expectations here as there are quite a few moving parts which have to go right to get anywhere close to these numbers.

Disc: Not a recommendation

2 Likes

Quick Market Check — Q2FY26 Edition

1) Q2FY26 Sense Check: Better Than Feared, Better Than Guided

Earnings season is sailing ahead of street estimates. Notably, small & mid caps have surprised with steady prints and—importantly—guidance holds/upsides for the next few quarters. Result reactions remain stock-specific; execution and balance-sheet quality are being rewarded.

2) Metals Up; Precious Metals Cool Off (But Not Broken)

Metals remain firm on demand/pricing traction.
Gold & Silver have cooled after a euphoric, crypto-like spike—a healthy reset. Structural supports (real-yield trend, reserve diversification, industrial silver demand) stay intact, but near-term expectations need a reset.

3) BESS: The Next Power Megatrend

Battery Energy Storage Systems (BESS) capex is in full flow globally and in India—utilities, C&I, and grid-stability projects are scaling. Think of BESS today as solar circa 2017: cost curves bending, policy scaffolding strengthening, and supply chains localizing. Key watchpoints:

  • Trajectory: VGF and PLIs, assembling, development, storage costs falling, stacking multiple revenue streams (peak shaving, frequency response).
  • Policy & tenders: Approval list of manufacturers, viability-gap funding, PLIs, and state procurement.
  • Domestic manufacturing: cells/modules/integration capacity building out.

Please watch the recent SOIC video on youtube to understand this sector in detail forever

4) Leadership: Large Caps First, Trickle-Down Next

As expected, headline indices & large caps lead; broader market still lags. With results better than feared, liquidity should trickle down, but be extremely choosy—track results and result reactions like a hawk and size positions accordingly.

5) Themes to Watch (With Quick Theses)

  • Pre Engineered Building Companies have reported solid numbers till now, against the expectations of a softer Q2 due to monsoons. H2 should be even better in this multi year megatrend. Look at the growth and guidance given by someone like EPACK Prefab

  • Microfinance players reporting good numbers with worst behind them. Track SFBs, MFIs and NBFCs closely. PSU Banks should also be tracked closely as the NIM compression is about to end. Valuations are cheap and growth should resume strongly here. Many banks will soon report a sharp fall in Cost to Income ratios leading to asymmetric bottomline growth - Ujjivan SFB, IDFC First, CSB Bank, AB Capital, etc. are some interesting names to study

  • Wealth Management Companies and AMCs have reported decent numbers till now. Watch out for the fastest growers with more recurring fee income base showing low cylicality and more structural growth going forward - Nuvama, 360 One, CRAMC, ABSLAMC, etc. look interesting. Gold financiers should report very strong numbers for the next few quarters - Muthoot, Fed Fina, etc.

  • Alcobev companies are showing a lot of strength, with Radico and GMB reporting out of the park numbers. Keep an eye on smaller players showing very solid strength on the charts following a similar playbook like Radico at a smaller scale - Allied Blenders, Tilaknagar, Associated Alcohol, Picadilly Agro, etc.

  • Platform companies like PB Fintech, CarTrade, Ixigo, etc. have reported fantastic numbers. Operating Leverage in such companies can create magic, especially in platform companies and should never be ignored. Do go through the latest investor presentations of these companies for super interesting insights on consumer trends, preferences and growth triggers

  • Realty companies are showing some bounceback but one has be extremely choosy here and allocate small in my opinion - Prestige, Oberoi, Suraj, Hubtown are some interesting names but nothing too exciting here

  • Auto OEMs and Auto Ancs continue to do well. This is another megatrend we discussed earlier. Many beneficiaries are showing solid growth and the charts are super strong. Positioning yourself in companies with multi year tailwinds, strong client base, regulatory beneficiaries and export optionalities will serve you well. Track SJS, Pricol, Lumax Twins, Minda Corp, etc.

  • Metals & mining + Steel tubes companies such as GPIL, Jayaswal Neco, Sarda, Shyam Metalics, Sambhv, APL Apollo, etc. have massive tailwinds, deleveraging and many of them have a lot of capex commercialisation coming soon which can lead to solid growth in the near term

  • Defence companies have gone under a time correction phase again - good time to study top companies like BEL, Data Patterns and interesing smaller players like Astramicro, Apollo Micro, Vinyas, etc.

  • Hospital companies can also do really well. Most recent tailwind was the rate hike for around 2000 medical procedures under the Central Government Health Scheme (CGHS), effective from October 13, 2025. Moreover, all the hospitals have alrady announced massive capex plans for bed additions. Another megatrend one should keep an eye out along with Diagnostic companies

Disc: Not a recommendation to buy/sell

17 Likes

AMC.pdf (743.1 KB)

1 Like

Stock Picking, Portfolio Construction & Capital Allocation — My Process

Over time, my investing has converged to one core belief:

Theme identification is underrated. Stock selection is often overrated.

Most mistakes arise not from picking bad companies, but from picking good companies in the wrong macro, sectoral, or cycle context. My process is designed to first align capital with structural tailwinds, and only then optimise stock-level decisions.


1. Start Top-Down: Identify Themes Before Stocks

The process begins with extensive reading of:

  • Industry and sector reports
  • Capex, policy, regulatory and supply-chain trends
  • Global analogues and cycle studies

The objective is to identify multi-year themes with:

  • Structural demand visibility
  • Clear beneficiaries in listed markets
  • Reasonable entry points over the cycle

Stock picking starts only after this exercise.


2. Bottom-Up Screening Within Identified Themes

Once themes are locked in, I move bottom-up.

  • Initial screening using fundamental + technical filters
  • Creation of a broad watchlist (≈50–100 names)
  • Hygiene filters: promoter quality, balance sheet, cash flows, liquidity, governance, execution history

This phase is deliberately inclusive. The goal is coverage, not conviction.


3. Narrowing the Research Funnel

The universe is progressively reduced:

  • Watchlist cut to ~30–40 names for focused work
  • Stocks aligned with sectoral/thematic tailwinds are prioritised
  • Extreme cyclicals are deprioritised unless valuations are asymmetric

This step reduces dependence on timing and improves downside protection.


4. Technical Stage Analysis as a Risk Filter

I then apply stage analysis to classify stocks into:

  • Relative outperformers
  • Neutral/base builders
  • Laggards or structurally weak setups

In weak or sideways markets, preference is clearly for:

Stocks outperforming the index and peers

Technicals are used not for trading, but to manage opportunity cost and capital efficiency.


5. Deep Dive: Fewer Stocks, Higher Quality Work

The list is further narrowed to 10–20 stocks.

For each:

  • Business and industry structure
  • Management quality and capital allocation
  • Rough financial models and scenario analysis
  • Clear articulation of thesis and risks

Precision forecasting is avoided. The focus is on range, durability, and asymmetry.


6. Final Prioritisation Framework

Stocks are ranked on a combined assessment of:

  • Sectoral tailwinds
  • Bear-case IRR (margin of safety over upside narratives)
  • Relative PEG
  • Technical strength and liquidity

Ideas that only work in optimistic scenarios do not qualify as high-weight bets.


7. Portfolio Construction Logic

  • Stocks passing most filters → smaller or medium positions
  • Stocks passing all filters → higher-weight positions

Position sizing reflects:

  • Downside protection
  • Research confidence
  • Liquidity and exit feasibility

8. Ongoing Review, Bench Strength & Capital Recycling

The portfolio is continuously compared against a bench of strong alternatives.

Key principles:

  • No emotional attachment to holdings
  • Objective comparison of risk-reward
  • Trimming as incremental IRR declines
  • Reallocating capital to superior setups

This ensures the portfolio evolves with markets and information.


9. Portfolio Size Discipline

I typically hold 15–25 stocks:

  • Concentrated enough to matter
  • Diversified enough to manage risk
  • Aligned with tracking bandwidth

Closing Thought

This process is not designed to maximise hit rates or predict short-term moves.

It is designed to:

  • Align capital with structural growth
  • Minimise permanent capital loss
  • Let probability and process compound over time

Markets change. A disciplined process is the only sustainable edge.

Hope this will be helpful!

16 Likes

Sectoral Idea: Nifty Metal

Let’s start from technicals straightaway - look at these two charts (weekly and monthly timeframes)


If you follow technical analysis, this is a typical early stage 2 behaviour on the charts after creating a pretty solid base. Risk reward seems fantastic here for the whole sector to do well in the coming 6-8 months at least.

Every once in a while, a sector gives you that rare combination of:

  • Clean technical structure, and
  • Multiple fundamental levers lining up at the same time.

Right now, Metals & Mining is starting to look like one of those setups. Let’s deep dive into fundamentals to understand why this rally might have just started and is much more than just a technical bet from here on:

The setup (why now?)

1) India’s domestic cycle is carrying the bat (infra + manufacturing + construction)

Unlike many global metal upcycles that depend entirely on China, this one has a strong India demand spine. Core infra, capex, housing, grid, rail, roads — the consumption engine is alive.
For metal producers, when volumes stay firm, operating leverage becomes your best friend.

Note: earnings upgrades come easier than people expect.


2) Electrification is not a theme — it’s a megatrend (Copper & Aluminium)

Power transmission, renewables, EV ecosystem, data centres, rail electrification, cables — this is a copper + aluminium heavy capex stream that doesn’t finish in one quarter.
Even a moderate acceleration shows up as persistent demand and improved spreads.

Note: copper/aluminium-linked names can stay in momentum mode longer than typical cyclicals.


3) Copper is where “tight supply” meets “steady demand”

Copper doesn’t need a booming world to rally — it just needs supply to stay constrained while demand stays “okay”. That’s where the asymmetry comes from.
Any incremental positivity (rate cuts, China stabilization, risk-on) and copper tends to react disproportionately.

Note: copper is a clean beta trade — and copper-linked stocks can move ahead of fundamentals.


4) China doesn’t need to boom — it just needs to be “less bad”

Most people wait for a clear China upcycle to buy metals. That’s usually late.
Cyclical rallies often start when the narrative shifts from “demand is collapsing” to “demand isn’t collapsing anymore.”
Restocking + policy expectations + currency moves can lift the entire complex even before hard data improves.

Note: you only need China to stop being a headwind for 2–3 quarters of tailwind.


5) Cost curves are behaving (margins can surprise)

Metals is not only about price — it’s about spreads and cost stability:

  • energy costs,
  • raw material linkages (alumina, coal, coking coal),
  • freight,
  • currency.

When input costs cool off or stabilize, you get positive margin surprise even with flat realizations.

Note: margin surprise = rerating + earnings upgrade = sector momentum continues


Precious metals overlay (because it matters for HZL + sentiment)

Silver – 2 reasons it can add torque

6) Silver has “squeeze potential” because the market is structurally tighter than people think

Silver is small, less liquid, and more prone to sharp moves. When investment demand returns, it can behave like a spring. Even a short phase of strong flows can create big price action.

Note: HZL (and the broader metal complex) can get a sentiment + earnings tailwind.

7) Silver has a rare dual engine: industrial + investment

Solar + electronics + electrification keeps the industrial base active.
Then, if rates soften / risk-on returns, investment demand can switch on quickly.

Note: silver can outperform in “risk-on but still uncertain” phases — which is exactly how markets often behave.


Gold – 2 reasons it supports the broader commodity mood

8) Gold remains the default hedge in an uncertain macro

When geopolitics, currency volatility, and policy uncertainty remain elevated, gold demand stays sticky. It doesn’t need daily triggers.

Note: a supported gold price often keeps the “commodity basket” bid going

9) If rates peak / soften, gold typically stays firm

Gold tends to do well when the market believes the rate cycle is peaking or easing. Even if growth is mixed, falling real yields (or the expectation of it) can keep gold supported.

Note: gold doesn’t need euphoria — it needs direction.


How one can play this (practical + stock-specific)

Sector calls are useless without a watchlist + execution plan.

Top ideas

Mining / raw materials / optionality

  • Ashapura Minechem
  • GPIL
  • Jayaswal Neco
  • GMDC
  • NMDC

Metals / converters

  • Hindustan Copper
  • Hindustan Zinc
  • National Aluminium (NALCO)
  • Hindalco

How I’d bucket them (helps sizing)

  • Quality/scale leaders: Hindalco, NALCO, Hindustan Zinc
  • High beta / optionality: Hind Copper, GMDC, NMDC
  • Special situations / smaller names: Ashapura, GPIL, Jayaswal Neco

Key Tracking Points:

  1. Nifty Metal index: breakout level + weekly closes
  2. Copper: price trend + reports on inventories / visible tightness
  3. Aluminium: spreads (alumina vs aluminium)
  4. Zinc / Lead / Silver: for Hindustan Zinc torque
  5. China: broad sentiment + restocking signals
  6. India: infra prints, cement/steel production, capex commentary
  7. Currency (USD/INR): impacts realizations and input costs
  8. Company-specific: utilization, cost curve commentary, expansions, volumes

The anti-thesis (what can go wrong)

A metals thesis is incomplete without the “kill switches”.

  1. Sharp global risk-off (commodities unwind together)
  2. China shock (policy disappointment, property drag worsens)
  3. Energy/input spike (spreads compress even if prices hold)
  4. Government interventions (duties, exports/import policy surprises)
  5. Company-specific execution risk (delays, grade issues, capex overruns)

My line in the sand:
If the index breakout fails and spreads start compressing at the same time, I treat it as “false start” and reduce risk quickly.


Closing thought

The best sector runs happen when:

  • the charts stop being noisy and start being clean, and
  • the fundamental story has multiple concurrent tailwinds.

Metals & Mining is starting to look like that again. It is a theme that is taking off and these businesses have very strong barriers to entry

Not because it’s a “forever theme” — but because for the next 2–3 quarters, the setup feels skewed in favour of upside: Domestic demand + global uncertainties + electrification pull + supply constraints in key metals + improving sentiment + potential margin surprises + AI led power demand, etc.

You can deep dive into each of the stock names mentioned above and see which fits your portfolio construct, buying crtiterion, risk-reward analysis and investment horizon.

Disc: Not a recommendation by any means

16 Likes

Cross-sector notes from the last few weeks (Metals, Autos, Jewellery, Financials, Recyclers, Health Foods)

Markets have a funny way of making you feel late and early at the same time.

Late — because the move looks obvious only after it’s already happened.
Early — because when the narrative is still building, most people underestimate how long trends can last.

This post is exactly that: some observations from different pockets of the market that I’m tracking closely. Not a “model portfolio”, not a set of calls — just signals, linkages, and what I’m watching next.

And yes — none of this is buy/sell advice.


1) Metals, Mining, Precious & Industrial metals: the trend has been relentless

Let’s call it what it is — Metals & Mining have been on an absolute tear, and the price action has been unusually “clean” across:

  • Silver + Copper (leading the pack, as expected),
  • Gold (holding up well),
  • Aluminium + Steel (quietly strong),
  • and of course, metal equities behaving like they’re pricing in a longer runway.

There will be time corrections — this sector never goes one-way forever. But what’s important is the underlying force of demand still looks strong, while the supply narrative keeps tightening.

And geopolitics, honestly, is only adding fuel.

Steel: safeguard duty could be the next trigger

With a fresh safeguard duty in place, steel names may get a fresh leg because the market loves two things:

  1. an improving spread story, and
  2. visible policy support.

If the tape stays strong, keep an eye on names like JSW Steel, Tata Steel, SAIL, Jindal Stainless, etc. The trade becomes simpler when policy aligns with the cycle.

MCX: the “obvious” beneficiary that’s still underappreciated

One of the biggest side-effects of commodity madness is not only on producers — it’s on platforms.

MCX is a direct beneficiary of this entire move:

  • commodity participation is rising,
  • brokers are pushing commodities more actively,
  • and newer segments like options are picking up real steam.
  • Volumes data shows over 100% YoY growth

When volatility rises and price discovery becomes a daily obsession, volumes explode — and you don’t need to be a commodities trader to understand why that matters.


2) Rising metal/alloy prices: watch the second-order impact on Auto & Auto Ancillaries

This is where it gets interesting.

Autos are in a good place:

  • demand cycle is healthy,
  • dealer checks are encouraging,
  • and structurally, kit value per vehicle is rising (more electronics, more premiumisation, more features, more complexity).

But when metals and alloys spike, the question becomes:
Can OEMs + ancillaries pass it through cleanly? Or do margins get pinched for a couple of quarters?

This is not something you can guess sitting at home — it will show up in:

  • commentary on pricing power,
  • raw material inflation guidance,
  • and how quickly pass-through catches up.

Management commentary is everything here.
The auto cycle can still be great, but near-term earnings can get choppy if input inflation moves faster than pricing.


3) Auto OEMs: dealer checks suggest the cycle is very strong

Dealer check data continues to point to strong momentum, with multiple OEMs showing high double-digit YoY growth.

A name I’m especially watching is Force Motors — because when the cycle turns in certain categories, stocks like these can surprise hard (both on growth and perception).

Also, if government focus shifts more meaningfully toward consumption-led growth, the auto cycle can get a longer runway than what most are modeling.

Track: booking/dispatch momentum, inventory levels, discounting trends, and any early signs of a margin squeeze due to metals.


4) Lab-grown diamonds: Titan entering could be a “disrupt yourself” masterstroke

Lab-grown diamonds are no longer niche — they’ve become normal.

Yes, there’s oversupply.
Yes, prices are lower and probably stay lower.
But here’s the part many people miss:

Lower price doesn’t always mean lower profitability — because:

  • lab-grown often has better margin structure, and
  • the game shifts toward volume + brand + retail execution.

If Titan is serious here, this could become a “disrupt yourself before someone else does” story.

In fact, this feels like a Zudio-like moment (in spirit, not in exact business model):
a large, trusted brand using scale + distribution + execution to build a category that becomes mass.

And honestly — the chart looks fantastic.
I’m quite bullish on Titan for the next year or so, especially if they execute this segment with the discipline they’re known for.

What I’m watching:

  • store-level traction,
  • pace of expansion,
  • marketing strategy and positioning

5) Banks & NBFCs: asset quality + strong parentage is showing up in price action

A lot of lenders are reminding the market of a simple truth:

In bad times, you survive because of asset quality.
In good times, you flourish because you already survived.

Names like Shriram Finance, L&T Finance, Muthoot, AB Capital, CSB Bank, RBL Bank, JM Financial, IIFL Finance, etc. are showing strength — and it’s not random.

CV financiers + gold financiers: tailwinds are strong

CV financiers are riding a healthy transport/capex cycle.
Gold financiers are benefiting from: high gold prices, strong demand, and improving confidence.

Also, the “under-discussed” point: Massive global capital flows into the sector lower cost of funds, which increases growth firepower when asset quality is supportive.

What I’m watching:

  • cost of funds
  • incremental disbursement growth,
  • NIM stability,
  • credit costs,
  • and any early signs of overheating.

6) Recyclers: the theme is quietly powerful (and can be very scalable)

This is a bucket I’m genuinely excited about.

Recycling is one of those themes where:

  • demand is steady,
  • capacity adds create step-up growth,
  • and the market often rewards execution disproportionately.

Pondy has been a big winner recently, and Gravita is a proven leader.
Other interesting names: Jain Resource Recycling, Baheti, etc.

New capacities kicking in (especially for names like Pondy) can create a strong near-term momentum window.

Track:

  • margins
  • capacity ramp up timelines,
  • realisation trends,
  • working capital discipline (very important here),
  • and evidence of sustainable ROCE.

7) One real-world megatrend I can’t ignore: health + protein is becoming mainstream

This is not a “Twitter trend”. It’s visible in real life.

People who never cared about ingredients are now:

  • reading labels,
  • choosing higher-protein meals,
  • switching to healthier snacking,
  • and actively tracking what they eat.

That change in behavior feels structural, not cyclical.

If you haven’t studied this theme in depth, you should. It’s a multi-year megatrend and will create multiple winners — not only in “health brands”, but also in:

  • dairy,
  • protein value chains,
  • and FMCG companies pivoting from slow-growth staples into higher growth value-added segments.

Some ideas that come to mind: Parag Milk, Zydus Wellness, Hatsun Agro — Keep and eye on the otherwise slow growing and boring FMCG basket and spot companies that may be quietly repositioning towards this high growth value added segment.

What I’m watching:

  • repeat consumption behavior (not just launch hype),
  • distribution expansion,
  • pricing power in premium SKUs,
  • and margin sustainability.

Closing thought

This post isn’t a recommendation list. It’s a map of where the energy is building — and where the second-order impacts might show up next.

If there’s one takeaway:
Big trends don’t move in isolation.
Metals impact autos. Precious metals change sentiment. Commodity volatility boosts exchanges. Consumer behavior creates brand winners. Financials thrive when credit cycles are clean.

That’s what makes markets fun.

As always: not buy/sell advice — just thoughts that might help you think better.

23 Likes

The growth in lab grown diamond may also positively impact the business of IGI.

3 Likes

Revisiting Entero Healthcare

Here are a few points to take note of:

  1. Massive supply overhang is out of the way after the exit of Smallcap World Fund as on 29th Dec
  2. ICICI MF has taken up the whole of the supply, buying around 5% of the company
  3. Stock has created a solid base and is hovering around key moving averages with a possible downside protection and demand zone creation around 950-1000 levels
  4. Fundamental thesis remains intact with Q3 expected to show first major signs of improvemet in WCC (targeting 60 days soon) and better margins with continued strong topline growth
  5. Contribution from recent acquisitions will start showing up as well from this quarter
  6. Big beneficiary of GLP-1 drugs distrubution
  7. Medtech is the new lever for fast growth and margin improvement
  8. Very confident management and proven track record

Risk reward for this company seems extremely favourable but this could very well be a decisive quarter for the company. Sectoral tailwinds are present and the valuations are quite reasonable for a company showing consistent outperformance (2-3x IPM growth) with an immaculate record of acquisition led growth. The TAM is massive and the shift to organised distrbutors is imminent - pace of shift will decide the growth rates of Entero going forward.

Disc: Not a recommendation. Please do your own research and consider your risk profile before making any investment decisions.

8 Likes

Titan’s Q3 Update

  • Fantastic all round update by the company
  • Core business growth of more than 40% YoY
  • International business grew at 79% YoY
  • Eyewear saw net reduction in stores acknowledging the lack of exponential growth in the category
  • Sectoral tailwinds in place with other players also expected to post solid numbers

Notes from the Company’s call:

LAB-GROWN DIAMOND STRATEGY & BRAND POSITIONING

  • LGD category still nascent in India with evolving unit economics; Titan spent 12+ months on customer research, pilots, and product testing before launch to understand pricing floor, customer confusion, and market readiness
  • ‘beYon’ targets younger demographics (18–35 demographic profile) seeking self-expression and indulgence rather than investment; pilot customers included hotel workers buying without family consultation and salaried women using personal savings for freedom of choice
  • No backward integration planned; sourcing from reputed external partners meeting Titan quality standards; products available in 14K and 18K gold plus limited silver testing; exchange value applies only to metal, not LGD stones
  • Marketing campaigns and consumer education rollout planned post-launch; will track customer acquisition mix (new vs existing Titan customers), purchase frequency, average ticket size, and younger segment penetration as key KPIs
  • Pricing strategy deliberately aggressive at Rs 23,000–25,000 per carat to attract price-sensitive, younger customers; wholesale prices significantly lower providing pricing flexibility as retail landscape stabilizes

The first store of ‘beYon’ is open and going by the economics of other LGD stores, the store level profitability journey is not long and can easily become profitable by selling just 1-2 items per day. I will be visiting the store soon and share my views with you guys but needless to say, I am excited about the prospects of this initiative.

As mentioned earlier, the chart looks in a solid early stage 2 with a new leg of outperformance journey in the near term. Let’s see how this plays out in the coming quarters

Disc: Not a recommendation to buy/sell

1 Like

Will Titin use IGIL cerification for Lab grown diamond